Axon exec awarded 24,371 shares in RSU grants

AXON ENTERPRISE, INC. executive Jeffrey C. Kunins reported equity compensation and related tax withholding activity.

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. executive Jeffrey C. Kunins reported equity compensation and related tax withholding activity. On August 16, 2026, he acquired 20,618 shares of common stock tied to a certified fourth tranche of performance-based restricted stock units under the 2024 eXponential Stock Plan and a supplemental grant of 3,753 shares, both at $0.00 per share. On August 13, 2026, 6,232.647 shares were disposed at $615.59 per share, representing shares withheld to settle tax liability from RSU vesting. He also reports 86,268 shares held indirectly through an LLC of which he is the sole member.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Kunins Jeffrey C

Role CPO & CTO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F2	20,618	$0.00	$0.00
Grant/Award	Common Stock F3	3,753	$0.00	$0.00
Tax Withholding	Common Stock F1	6,232.647	$615.59	$3.84M
holding	Common Stock F4	--	--	--

Holdings After Transaction: Common Stock — 107,366.17 shares (Direct); Common Stock — 86,268 shares (Indirect, Shares owned by LLC)

Footnotes (4)

1. F1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.
2. F2. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.
3. F3. This award represents a supplemental grant approved by the Compensation Committee to implement the executive compensation program as intended with respect to the treatment of future XSP tranches.
4. F4. Shares that are indicated as being "owned by LLC" are owned indirectly by the reporting person as the sole member of the LLC.

Key Figures

Performance-based RSU tranche shares: 20,618 shares Supplemental grant shares: 3,753 shares Tax-withholding shares disposed: 6,232.647 shares +4 more

7 metrics

Performance-based RSU tranche shares 20,618 shares Fourth tranche of XSUs certified on August 16, 2026 under 2024 eXponential Stock Plan

Supplemental grant shares 3,753 shares Supplemental equity grant approved by Compensation Committee

Tax-withholding shares disposed 6,232.647 shares Shares withheld on August 13, 2026 to settle tax liability from RSU vesting

Tax-withholding price per share $615.59 per share Price applied to shares delivered or withheld for tax liability

Indirect LLC holdings 86,268 shares Common stock held indirectly as shares owned by LLC

Minimum holding period end date December 31, 2030 Earliest date shares from the Tranche may be released absent later tranche vesting

Tranche vesting date December 1, 2026 Scheduled vesting date for the certified XSUs tranche, subject to continued employment

Key Terms

performance-based restricted stock units, 2024 eXponential Stock Plan, minimum holding period, tax liability, +1 more

5 terms

performance-based restricted stock units financial

"The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

2024 eXponential Stock Plan financial

"pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which"

minimum holding period financial

"the shares deliverable for the Tranche are subject to a minimum holding period"

tax liability financial

"securities withheld to settle the reporting person's tax liability resulting from"

supplemental grant financial

"This award represents a supplemental grant approved by the Compensation Committee"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did AXON (AXON) executive Jeffrey C. Kunins receive on August 16, 2026?

Jeffrey C. Kunins received equity awards totaling 24,371 shares of Axon common stock on August 16, 2026, consisting of 20,618 shares from a performance-based RSU tranche and a supplemental grant of 3,753 shares, both at $0.00 per share.

What is the nature of the 20,618-share award to AXON (AXON) executive Jeffrey C. Kunins?

The 20,618-share award is a tranche of performance-based restricted stock units under Axon’s 2024 eXponential Stock Plan, with performance conditions for this tranche certified on August 16, 2026 and scheduled to vest on December 1, 2026, subject to continued employment.

Why did AXON (AXON) executive Jeffrey C. Kunins dispose of 6,232.647 shares on August 13, 2026?

On August 13, 2026, 6,232.647 shares of Axon common stock were disposed at $615.59 per share to settle tax liability arising from the vesting of restricted stock units, through securities withheld rather than an open-market sale.

How many AXON (AXON) shares does Jeffrey C. Kunins hold indirectly through an LLC?

Jeffrey C. Kunins reports 86,268 shares of Axon common stock held indirectly as shares “owned by LLC.” A footnote states these are owned indirectly by him as the sole member of the LLC.

What is the supplemental equity grant reported for AXON (AXON) executive Jeffrey C. Kunins?

A supplemental grant of 3,753 shares of Axon common stock was approved by the Compensation Committee to implement the executive compensation program as intended with respect to the treatment of future eXponential Stock Plan tranches.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 05:31 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunins Jeffrey C

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CPO & CTO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		F(1)		6,232.647	D	$615.59	82,995.17	D
Common Stock	08/16/2026		A(2)		20,618	A	$0	103,613.17	D
Common Stock	08/16/2026		A(3)		3,753	A	$0	107,366.17	D
Common Stock								86,268	I	Shares owned by LLC(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.

2. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on December 22, 2023 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the fourth tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on August 16, 2026 as having been met. The Tranche will vest on December 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

3. This award represents a supplemental grant approved by the Compensation Committee to implement the executive compensation program as intended with respect to the treatment of future XSP tranches.

4. Shares that are indicated as being "owned by LLC" are owned indirectly by the reporting person as the sole member of the LLC.

Remarks:

	/s/ Jeffrey C. Kunins, by Isaiah Fields, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)